BRICANYL 0.5 mg/1 ml, solution for injection in an ampoule 10 ampoules of 1 ml
Active ingredients: Terbutaline sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 1 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRICANYL 0,5 mg/1 ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 10 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- ASTRAZENECA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Feb 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62600742CIP73921574CIP133400939215747Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE TERBUTALINEsolution | 0,5 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.